PATENT CLAIM ANALYSIS

Application Number: 16139617
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "654000"]

Abstract:
A method of increasing an average time between seizures in a human patient diagnosed with Dravet syndrome, comprising administering to the patient a therapeutically effective dose of fenfluramine or a pharmaceutically acceptable salt, base, acid or amine thereof, and repeating the administering over a period of days until the patient exhibits an increase from baseline in average time between convulsive seizures of 6 hours, days weeks or more.

Claim (Index 13):
The method of  claim 1 , further comprising:\n repeating the administering until the patient is seizure free for a period of \u22659 days.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 97.0
- Lexical Diversity: 1.48
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15449177', '15449084', '15948412', '15449204', '15449124']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7194877168373134
- 35 USC 102 Novelty (BERT): 0.5394725264249136
- Combined Prediction Score: 0.7014861977960734
- Mean Citation Score: 352.021696
- Max Citation Score: 355.40964
- Similarity Product: 172.2987630370939

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test